Doc Generici Overview

  • Founded
  • 1996

Founded
  • Status
  • Private

  • Employees
  • 189

Employees
  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 6

  • Investments
  • 1

Doc Generici General Information

Description

Manufacturer and wholesaler of generic pharmaceutical products intended for cardiovascular, gastrointestinal, metabolism and neurological treatments. The company provides drugs for the treatment of common medical conditions with a broad product portfolio with proven efficacy, enabling patients to get inexpensive yet effective medication for treating a wide variety of diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Via Filippo Turati, 40
  • 20121 Milan
  • Italy
+39 02 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Doc Generici Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Doc Generici‘s full profile, request access.

Request a free trial

Doc Generici Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and wholesaler of generic pharmaceutical products intended for cardiovascular, gastrointestinal, metabolism
Pharmaceuticals
Milan, Italy
189 As of 2022
000000000000

000000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
000000000000000
Basel, Switzerland
00000 As of 0000
000000000-00

00000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
000000000000000
Lyon, France
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Doc Generici Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sandoz International Corporate Backed or Acquired Basel, Switzerland 00000 000000000-00
00000 Formerly VC-backed Lyon, France 00 00000 000000000 00000
000000 Formerly VC-backed Lyon, France 000 000.00 00000000 000.00
0000000000000 Corporation Montreal, Canada 0000 00000000000
000000000 Venture Capital-Backed Milan, Italy 00 000.00 00000000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Doc Generici Executive Team (4)

Name Title Board Seat Contact Info
Riccardo Zagaria Chief Executive Officer
Alberto Villa Chief Financial Officer
Stefano Cortesi Finance Director
You’re viewing 3 of 4 executive team members. Get the full list »

Doc Generici Board Members (5)

Name Representing Role Since
000000000 00000000 Doc Generici Chairman 000 0000
0000000 000000000 TPG Board Member 000 0000
0000 000000 TPG Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Doc Generici Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Doc Generici Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Doc Generici‘s full profile, request access.

Request a free trial

Doc Generici Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (0000 08-Aug-2022 0000000000 Drug Delivery 00000000
To view Doc Generici’s complete investments history, request access »